Qualitest Approved for Levetiracetam Oral Solution
Keppra oral solution is indicated for adjunct treatment in partial onset seizures in patients ≥1month old, myoclonic seizures in patients ≥12yrs old with juvenile myoclonic epilepsy, adjunct in primary generalized tonic-clonic seizures in patients ≥6yrs old with idiopathic generalized epilepsy.
Levetiracetam oral solution will be available from Qualitest in 100mg/mL dosage strength. The product is expected to be launched by mid-2012.
For more information call (800) 462-ENDO or visit www.endo.com.